We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$13.8B
AUM Growth
+$986M
Cap. Flow
+$685M
Cap. Flow %
4.96%
Top 10 Hldgs %
50.39%
Holding
4,806
New
368
Increased
1,624
Reduced
1,118
Closed
315

Sector Composition

Rank Sector Weight
1 Energy 5.61%
2 Financials 4.67%
3 Technology 3.17%
4 Healthcare 2.39%
5 Communication Services 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBR icon
3526
ProShares Ultra MSCI Brazil Capped
UBR
$3.85M
$6K ﹤0.01%
+125
New +$5.16K
UE icon
3527
Urban Edge Properties
UE
$2.94B
$6K ﹤0.01%
209
-6
-3% -$161
URG
3528
Ur-Energy
URG
$485M
$6K ﹤0.01%
10,100
+7,750
+330% +$4.11K
VRDN icon
3529
Viridian Therapeutics
VRDN
$2.13B
$6K ﹤0.01%
59
WIX icon
3530
WIX.com
WIX
$2.15B
$6K ﹤0.01%
+200
New +$5.11K
YHGJ icon
3531
Yunhong Green CTI Ltd
YHGJ
$7.25M
$6K ﹤0.01%
90
-10
-10% -$660
TBCH
3532
Turtle Beach Corp
TBCH
$239M
$6K ﹤0.01%
1,500
-100
-6% -$411
SEEL
3533
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
NUVA
3534
DELISTED
NuVasive, Inc.
NUVA
$6K ﹤0.01%
108
+100
+1,250% +$5.41K
MN
3535
DELISTED
MANNING & NAPIER, INC.
MN
$6K ﹤0.01%
650
+200
+44% +$1.76K
SMM
3536
DELISTED
Salient Midstream & MLP Fund
SMM
$6K ﹤0.01%
572
SRGA
3537
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$6K ﹤0.01%
52
SUNS
3538
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$6K ﹤0.01%
400
MCEP
3539
DELISTED
Mid-Con Energy Partners, LP
MCEP
$6K ﹤0.01%
+156
New +$8.59K
AXAS
3540
DELISTED
Abraxas Petroleum Corp
AXAS
$6K ﹤0.01%
255
ROYT
3541
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$6K ﹤0.01%
3,000
UNT
3542
DELISTED
UNIT Corporation
UNT
$6K ﹤0.01%
380
RDC
3543
DELISTED
Rowan Companies Plc
RDC
$6K ﹤0.01%
353
ECYT
3544
DELISTED
Endocyte, Inc. Common Stock
ECYT
$6K ﹤0.01%
2,000
GST
3545
DELISTED
Gastar Exploration Inc.
GST
$6K ﹤0.01%
5,300
-350,200
-99% -$413K
ANTH
3546
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$6K ﹤0.01%
250
RPXC
3547
DELISTED
RPX Corporation
RPXC
$6K ﹤0.01%
+600
New +$6.04K
FINL
3548
DELISTED
Finish Line
FINL
$6K ﹤0.01%
309
-298
-49% -$5.63K
ADRE
3549
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$6K ﹤0.01%
200
WG
3550
DELISTED
Willbros Group
WG
$6K ﹤0.01%
2,500

Similar funds

Creative Planning's Q2 2016 Portfolio in Review

As of Q2 2016, Creative Planning held 4,806 positions worth $13.8B, up 7.7% from $12.8B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Creative Planning deployed $685M of net new capital in Q2 2016, opening 368 new positions and adding to 1,624 existing holdings. Its largest new stake was iShares MSCI United Kingdom Small-Cap ETF: 65,000 shares worth $2.21M.

By sector, the portfolio is most concentrated in Energy at 5.6% of assets, up from 5.1% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Gentex, an estimated $36.5M trimmed.

  • Creative Planning's largest Q2 2016 buy was iShares MSCI United Kingdom Small-Cap ETF: 65,000 shares worth $2.21M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2016, an estimated $74.6M increase.
  • Creative Planning's biggest Q2 2016 reduction was Gentex, cutting an estimated $36.5M.
  • Creative Planning fully exited NUVEEN MUNICIPAL OPPORTUNITY FUND INC in Q2 2016, selling an estimated $2.6M.
  • Creative Planning's ten largest holdings make up 50% of its $13.8B portfolio in Q2 2016.
  • Creative Planning opened 368 new positions and closed 315 in Q2 2016.
  • Creative Planning's portfolio value rose 7.7% quarter-over-quarter to $13.8B.

Based on Creative Planning's 13F filing for Q2 2016, filed 12 Jul 2016.